<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/rss.css" type="text/css"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
    xmlns:cc="http://web.resource.org/cc/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:extra="http://www.w3.org/1999/xhtml"
    xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <channel rdf:about="http://www.biomedcentral.com/feeds/mostaccessed/journal?journal=bmcpublichealth&amp;quantity=&amp;format=rss&amp;version=">
        <title>BMC Public Health - Most accessed articles</title>
        <link>http://www.biomedcentral.com/bmcpublichealth/</link>
        <description>The most accessed research articles published by BMC Public Health</description>
        <dc:date>2009-11-01T00:00:00Z</dc:date>
        <items>
            <rdf:Seq>
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2458/9/295" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2458/9/380" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2458/9/404" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2458/9/402" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2458/9/401" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2458/9/390" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2458/9/397" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2458/9/403" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2458/9/51" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2458/9/395" />
                            </rdf:Seq>
        </items>
        <extra:info rdf:parseType="Literal">
            <html:div style="font:14px Verdana, Geneva, Arial, Helvetica, sans-serif" xmlns:html="http://www.w3.org/1999/xhtml">
                <html:span style="font-weight:bold">
                    This is an RSS newsfeed from BioMed Central
                </html:span>
                <html:br />
                <html:span style="font-size: 12px;">
                    It is intended to be used with an RSS reader. For more information about RSS newsfeeds from BioMed Central, visit
                    <html:br />
                    <html:a href="http://www.biomedcentral.com/info/about/rss/" style="color:#3333CC; font-size:12px;">
                        http://www.biomedcentral.com/info/about/rss/
                    </html:a>
                    <html:br />
                </html:span>
            </html:div>
        </extra:info>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </channel>
        <item rdf:about="http://www.biomedcentral.com/1471-2458/9/295">
        <title>Persistant circulating unmetabolised folic acid in a setting of liberal voluntary folic acid fortification. Implications for further mandatory fortification? </title>
        <description>Background:
Ireland is an example of a country that has extensive voluntary fortification with folic acid. After a public consultation process, in 2006, the Food Safety Authority in Ireland FSAI 1 recommended mandatory fortification. However due to safety considerations this decision is now on hold. Before mandatory fortification goes ahead, existing levels of unmetabolised folic acid and their anticipated increase after fortification needs investigation because of the potential of folic acid to mask pernicious anaemia and possibly accelerate the growth of existing cancers. The aim of this study was to examine the levels of circulatory unmetabolised folic acid in Irish adults (both fasted and un-fasted) and new-born infants (fasted) before the proposed implementation of mandatory folic acid fortification. A secondary aim was to predict the increase in circulatory unmetabolised folic acid levels after fortification.
Methods:
Study 1. Setting: Irish Blood Transfusion Service (IBTS). Whole blood samples were collected from blood donors (n = 50) attending for routine blood donation sessions (representing the general population). Subjects were not fasted prior to sampling. Study 2. Setting: Coombe Women&apos;s and Infant&apos;s University Hospital, Dublin. Whole blood samples were collected by venipuncture from mothers (n = 20), and from their infant&apos;s umbilical-cords (n = 20) immediately after caesarean section. All women had been fasted for at least 8 hours prior to the surgery. A questionnaire on habitual and recent dietary intakes of folic acid was administered by an interviewer to all subjects. The data collection period was February to April 2006. Serum samples were analysed for plasma folate, plasma folic acid and red cell folate.
Results:
Blood Donor Group: Circulatory unmetabolised folic acid was present in 18 out of 20 mothers (fasted) (CI: 68.3%&#8211;99.8%) comprising 1.31% of total plasma folate, 17 out of 20 babies (fasted) (CI: 62.1%&#8211;96.8%), and 49 out of 50 blood donors (unfasted) (CI: 88.0%&#8211;99.9%), comprising 2.25% of total plasma folate,
Conclusion:
While the levels of circulatory unmetabolised folic acid reported are low, it is persistently present in women immediately after caesarean section who were fasting indicating that there would be a constant/habitual exposure of existing tumours to folic acid, with the potential for accelerated growth. Mandatory fortification might exacerbate this. This has implications for those with responsibility for drafting legislating in this area.</description>
        <link>http://www.biomedcentral.com/1471-2458/9/295</link>
                <dc:creator>Mary Sweeney</dc:creator>
                <dc:creator>Anthony Staines</dc:creator>
                <dc:creator>Leslie Daly</dc:creator>
                <dc:creator>Aisling Traynor</dc:creator>
                <dc:creator>Sean Daly</dc:creator>
                <dc:creator>Steve Bailey</dc:creator>
                <dc:creator>Patricia Alverson</dc:creator>
                <dc:creator>June Ayling</dc:creator>
                <dc:creator>John Scott</dc:creator>
                <dc:source>BMC Public Health 2009, 9:295</dc:source>
        <dc:date>2009-08-18T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2458-9-295</dc:identifier>
        <prism:publicationName>BMC Public Health</prism:publicationName>
        <prism:issn>1471-2458</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>295</prism:startingPage>
        <prism:publicationDate>2009-08-18T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2458/9/380">
        <title>Teenage drinking, alcohol availability and pricing: a cross-sectional study of risk and protective factors for alcohol-related harms in school children</title>
        <description>Background:
There is a lack of empirical analyses examining how alcohol consumption patterns in children relate to harms. Such intelligence is required to inform parents, children and policy relating to the provision and use of alcohol during childhood. Here, we examine drinking habits and associated harms in 15-16 year olds and explore how this can inform public health advice on child drinking.
Methods:
An opportunistic survey of 15-16 year olds (n = 9,833) in North West England was undertaken to determine alcohol consumption patterns, drink types consumed, drinking locations, methods of access and harms encountered. Cost per unit of alcohol was estimated based on a second survey of 29 retail outlets. Associations between demographics, drinking behaviours, alcohol pricing and negative outcomes (public drinking, forgetting things after drinking, violence when drunk and alcohol-related regretted sex) were examined.
Results:
Proportions of drinkers having experienced violence when drunk (28.8%), alcohol-related regretted sex (12.5%) and forgetting things (45.3%), or reporting drinking in public places (35.8%), increased with drinking frequency, binge frequency and units consumed per week. At similar levels of consumption, experiencing any negative alcohol-related outcome was lower in those whose parents provided alcohol. Drunken violence was disproportionately associated with being male and greater deprivation while regretted sex and forgetting things after drinking were associated with being female. Independent of drinking behaviours, consuming cheaper alcohol was related to experiencing violence when drunk, forgetting things after drinking and drinking in public places.
Conclusion:
There is no safe level of alcohol consumption for 15-16 year olds. However, while abstinence removes risk of harms from personal alcohol consumption, its promotion may also push children into accessing drink outside family environments and contribute to higher risks of harm. Strategies to reduce alcohol-related harms in children should ensure bingeing is avoided entirely, address the excessively low cost of many alcohol products, and tackle the ease with which it can be accessed, especially outside of supervised environments.</description>
        <link>http://www.biomedcentral.com/1471-2458/9/380</link>
                <dc:creator>Mark Bellis</dc:creator>
                <dc:creator>Penelope Phillips-Howard</dc:creator>
                <dc:creator>Karen Hughes</dc:creator>
                <dc:creator>Sara Hughes</dc:creator>
                <dc:creator>Penny Cook</dc:creator>
                <dc:creator>Michela Morleo</dc:creator>
                <dc:creator>Kerin Hannon</dc:creator>
                <dc:creator>Linda Smallthwaite</dc:creator>
                <dc:creator>Lisa Jones</dc:creator>
                <dc:source>BMC Public Health 2009, 9:380</dc:source>
        <dc:date>2009-10-09T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2458-9-380</dc:identifier>
        <prism:publicationName>BMC Public Health</prism:publicationName>
        <prism:issn>1471-2458</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>380</prism:startingPage>
        <prism:publicationDate>2009-10-09T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2458/9/404">
        <title>The Healthy Steps Study: A randomized controlled trial of a pedometer-based Green Prescription for older adults: Trial protocol</title>
        <description>Background:
Graded health benefits of physical activity have been demonstrated for the reduction of coronary heart disease, some cancers, and type-2 diabetes, and for injury reduction and improvements in mental health. Older adults are particularly at risk of physical inactivity, and would greatly benefit from successful targeted physical activity interventions.Methods/DesignThe Healthy Steps study is a 12-month randomized controlled trial comparing the efficacy of a pedometer-based Green Prescription with the conventional time-based Green Prescription in increasing and maintaining physical activity levels in low-active adults over 65 years of age. The Green Prescription interventions involve a primary care physical activity prescription with 3 follow-up telephone counselling sessions delivered by trained physical activity counsellors over 3 months. Those in the pedometer group received a pedometer and counselling based around increasing steps that can be monitored on the pedometer, while those in the standard Green Prescription group received counselling using time-based goals. Baseline, 3 month (end of intervention), and 12 month measures were assessed in face-to-face home visits with outcomes measures being physical activity (Auckland Heart Study Physical Activity Questionnaire), quality of life (SF-36 and EQ-5D), depressive symptoms (Geriatric Depression Scale), blood pressure, weight status, functional status (gait speed, chair stands, and tandem balance test) and falls and adverse events (self-report). Utilisation of health services was assessed for the economic evaluation carried out alongside this trial. As well, a process evaluation of the interventions and an examination of barriers and motives for physical activity in the sample were conducted. The perceptions of primary care physicians in relation to delivering physical activity counselling were also assessed.DiscussionThe findings from the Healthy Steps trial are due in late 2009. If successful in improving physical activity in older adults, the pedometer-based Green Prescription could assist in reducing utilisation of health services and improve cardiovascular health and reduction of risk for a range of non-communicable lifestyles diseases.Trial registrationAustralian and New Zealand Clinical Trials Registry ACTRN012606000023550</description>
        <link>http://www.biomedcentral.com/1471-2458/9/404</link>
                <dc:creator>Gregory Kolt</dc:creator>
                <dc:creator>Grant Schofield</dc:creator>
                <dc:creator>Ngaire Kearse</dc:creator>
                <dc:creator>Nick Garrett</dc:creator>
                <dc:creator>Philip Schluter</dc:creator>
                <dc:creator>Toni Ashton</dc:creator>
                <dc:creator>Asmita Patel</dc:creator>
                <dc:source>BMC Public Health 2009, 9:404</dc:source>
        <dc:date>2009-11-01T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2458-9-404</dc:identifier>
        <prism:publicationName>BMC Public Health</prism:publicationName>
        <prism:issn>1471-2458</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>404</prism:startingPage>
        <prism:publicationDate>2009-11-01T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2458/9/402">
        <title>General symptom reporting in female fibromyalgia patients and referents: a population-based case-referent study

</title>
        <description>Background:
Fibromyalgia is characterized by widespread musculoskeletal pain and palpation tenderness. In addition to these classic symptoms, fibromyalgia patients tend to report a number of other complaints. What these other complaints are and how often they are reported as compared with related referents from the general population is not very well known. We therefore hypothesized that subjects with fibromyalgia report more of a wide range of symptoms as compared with referents of the same sex and age from the general population.
Methods:
138 women with diagnosed fibromyalgia in primary health care and 401 referents from the general population matched to the cases by sex, age and residential area responded to a postal questionnaire where information on marital status, education, occupational status, income level, immigrant status, smoking habits physical activity, height and weight history and the prevalence of 42 defined symptoms was sought.
Results:
The cases had lower educational and income levels, were more often unemployed, on sick leave or on disability pension and were more often first generation immigrants than the referents. They were also heavier, shorter and more often had a history of excessive food intake and excessive weight loss. When these differences were taken into account, cases reported not only significantly more presumed fibromyalgia symptoms but also significantly more of general symptoms than the referents. The distribution of symptoms was similar in subjects with fibromyalgia and referents, indicating a generally higher symptom reporting level among the former.
Conclusion:
Subjects with fibromyalgia had a high prevalence of reported general symptoms than referents. Some of these differences may be a consequence of the disorder while others may reflect etiological processes.</description>
        <link>http://www.biomedcentral.com/1471-2458/9/402</link>
                <dc:creator>Karin Bjorkegren</dc:creator>
                <dc:creator>Mari-Ann Wallander</dc:creator>
                <dc:creator>Saga Johansson</dc:creator>
                <dc:creator>Kurt Svardsudd</dc:creator>
                <dc:source>BMC Public Health 2009, 9:402</dc:source>
        <dc:date>2009-10-31T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2458-9-402</dc:identifier>
        <prism:publicationName>BMC Public Health</prism:publicationName>
        <prism:issn>1471-2458</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>402</prism:startingPage>
        <prism:publicationDate>2009-10-31T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2458/9/401">
        <title>A cost-utility analysis of cervical cancer vaccination in preadolescent Canadian females</title>
        <description>Background:
Despite the fact that approximately 70% of Canadian women undergo cervical cancer screening at least once every 3 years, approximately 1,300 women were diagnosed with cervical cancer and approximately 380 died from it in 2008. This study estimates the effectiveness and cost-effectiveness of vaccinating 12-year old Canadian females with an AS04-adjuvanted cervical cancer vaccine. The indirect effect of vaccination, via herd immunity, is also estimated.
Methods:
A 12-health-state 1-year-cycle Markov model was developed to estimate lifetime HPV related events for a cohort of 12-year old females. Annual transition probabilities between health-states were derived from published literature and Canadian population statistics. The model was calibrated using Canadian cancer statistics. From a healthcare perspective, the cost-effectiveness of introducing a vaccine with efficacy against HPV-16/18 and evidence of cross-protection against other oncogenic HPV types was evaluated in a population undergoing current screening practices. The base-case analysis included 70% screening coverage, 75% vaccination coverage, $135/dose for vaccine, and 3% discount rate on future costs and health effects. Conservative herd immunity effects were taken into account by estimated HPV incidence using a mathematical model parameterized by reported age-stratified sexual mixing data. Sensitivity analyses were performed to address parameter uncertainties.
Results:
Vaccinating 12-year old females (n = 100,000) was estimated to prevent between 390-633 undiscounted cervical cancer cases (reduction of 47%-77%) and 168-275 undiscounted deaths (48%-78%) over their lifetime, depending on whether or not herd immunity and cross-protection against other oncogenic HPV types were included. Vaccination was estimated to cost $18,672-$31,687 per QALY-gained, the lower range representing inclusion of cross-protective efficacy and herd immunity. The cost per QALY-gained was most sensitive to duration of vaccine protection, discount rate, and the correlation between probability of screening and probability of vaccination.
Conclusion:
In the context of current screening patterns, vaccination of 12-year old Canadian females with an ASO4-ajuvanted cervical cancer vaccine is estimated to significantly reduce cervical cancer and mortality, and is a cost-effective option. However, the economic attractiveness of vaccination is impacted by the vaccine&apos;s duration of protection and the discount rate used in the analysis.</description>
        <link>http://www.biomedcentral.com/1471-2458/9/401</link>
                <dc:creator>Andrea Anonychuk</dc:creator>
                <dc:creator>Chris Bauch</dc:creator>
                <dc:creator>Maraki Fikre Merid</dc:creator>
                <dc:creator>Georges Van Kriekinge</dc:creator>
                <dc:creator>Nadia Demarteau</dc:creator>
                <dc:source>BMC Public Health 2009, 9:401</dc:source>
        <dc:date>2009-10-31T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2458-9-401</dc:identifier>
        <prism:publicationName>BMC Public Health</prism:publicationName>
        <prism:issn>1471-2458</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>401</prism:startingPage>
        <prism:publicationDate>2009-10-31T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2458/9/390">
        <title>Formative research on the feasibility of hygiene interventions for influenza control in UK primary schools </title>
        <description>Background:
Interventions to increase hand washing in schools have been advocated as a means to reduce the transmission of pandemic influenza and other infections. However, the feasibility and acceptability of effective school-based hygiene interventions is not clear.
Methods:
A pilot study in four primary schools in East London was conducted to establish the current need for enhanced hand hygiene interventions, identify barriers to their implementation and to test their acceptability and feasibility. The pilot study included key informant interviews with teachers and school nurses, interviews, group discussions and essay questions with the children, and testing of organised classroom hand hygiene activities.
Results:
In all schools, basic issues of personal hygiene were taught especially in the younger age groups. However, we identified many barriers to implementing intensive hygiene interventions, in particular time constraints and competing health issues. Teachers&apos; motivation to teach hygiene and enforce hygienic behaviour was primarily educational rather than immediate infection control. Children of all age groups had good knowledge of hygiene practices and germ transmission.
Conclusion:
The pilot study showed that intensive hand hygiene interventions are feasible and acceptable but only temporarily during a period of a particular health threat such as an influenza pandemic, and only if rinse-free hand sanitisers are used. However, in many settings there may be logistical issues in providing all schools with an adequate supply. In the absence of evidence on effectiveness, the scope for enhanced hygiene interventions in schools in high income countries aiming at infection control appears to be limited in the absence of a severe public health threat.</description>
        <link>http://www.biomedcentral.com/1471-2458/9/390</link>
                <dc:creator>Wolf-Peter Schmidt</dc:creator>
                <dc:creator>Catherine Wloch</dc:creator>
                <dc:creator>Adam Biran</dc:creator>
                <dc:creator>Val Curtis</dc:creator>
                <dc:creator>Punam Pangtani</dc:creator>
                <dc:source>BMC Public Health 2009, 9:390</dc:source>
        <dc:date>2009-10-15T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2458-9-390</dc:identifier>
        <prism:publicationName>BMC Public Health</prism:publicationName>
        <prism:issn>1471-2458</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>390</prism:startingPage>
        <prism:publicationDate>2009-10-15T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2458/9/397">
        <title>Chlamydia trachomatis infection and sexual behaviour among female students attending higher education in the Republic of Ireland.</title>
        <description>Background:
There are no prevalence data on Chlamydia trachomatis relating to female students attending higher education available for the Republic of Ireland. This information is required to guide on the necessity for Chlamydia screening programmes in higher education settings. This research aimed to determine the prevalence of and predictive risk factors for Chlamydia trachomatis genital infection among female higher education students in Ireland.
Methods:
All females presenting during one-day periods at Student Health Units in three higher education institutions in two cities in the Republic of Ireland were invited to participate. Participants completed a questionnaire on lifestyle and socio-demographic factors and provided a urine sample. Samples were tested for C. trachomatis DNA by a PCR based technique (Cobas Amplicor, Roche). To examine possible associations between a positive test and demographic and lifestyle risk factors, a univariate analysis was performed. All associations with a p value &lt; 0.05 were included in a multivariate logistic regression analysis.
Results:
Of the 460 sexually active participants 22 tested positive (prevalence 4.8%; 95% CI 3.0 to 7.1%). Variables associated with significantly increased risk were current suggestive symptoms, two or more one-night stands and three or more lifetime sexual partners. The students displayed high-risk sexual behaviour.
Conclusion:
The prevalence of C. trachomatis infection and the lack of awareness of the significance of suggestive symptoms among sexually experienced female students demonstrate the need for a programme to test asymptomatic or non-presenting higher education students. The risk factors identified by multivariate analysis may be useful in identifying those who are most likely to benefit from screening. Alcohol abuse, condom use, sexual behaviour (at home and abroad) and, knowledge of sexually transmitted infections (STIs) (including asymptomatic nature or relevant symptoms) were identified as target areas for health promotion strategies. These strategies are needed in view of the high-risk sexual activity identified.</description>
        <link>http://www.biomedcentral.com/1471-2458/9/397</link>
                <dc:creator>Emer O'Connell</dc:creator>
                <dc:creator>Wendy Brennan</dc:creator>
                <dc:creator>Martin Cormican</dc:creator>
                <dc:creator>Marita Glacken</dc:creator>
                <dc:creator>Diarmuid O'Donovan</dc:creator>
                <dc:creator>Akke Vellinga</dc:creator>
                <dc:creator>Niall Cahill</dc:creator>
                <dc:creator>Fionnguala Lysaght</dc:creator>
                <dc:creator>Joan O'Donnell</dc:creator>
                <dc:source>BMC Public Health 2009, 9:397</dc:source>
        <dc:date>2009-10-29T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2458-9-397</dc:identifier>
        <prism:publicationName>BMC Public Health</prism:publicationName>
        <prism:issn>1471-2458</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>397</prism:startingPage>
        <prism:publicationDate>2009-10-29T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2458/9/403">
        <title>Supporting adolescent emotional health in schools: a mixed methods study of student and staff views in England</title>
        <description>Background:
Schools have been identified as an important place in which to support adolescent emotional health, although evidence as to which interventions are effective remains limited. Relatively little is known about student and staff views regarding current school-based emotional health provision and what they would like to see in the future, and this is what this study explored.
Methods:
A random sample of 296 English secondary schools were surveyed to quantify current level of emotional health provision. Qualitative student focus groups (27 groups, 154 students aged 12-14) and staff interviews (12 interviews, 15 individuals) were conducted in eight schools, purposively sampled from the survey respondents to ensure a range of emotional health activity, free school meal eligibility and location. Data were analysed thematically, following a constant comparison approach.
Results:
Emergent themes were grouped into three areas in which participants felt schools did or could intervene: emotional health in the curriculum, support for those in distress, and the physical and psychosocial environment. Little time was spent teaching about emotional health in the curriculum, and most staff and students wanted more. Opportunities to explore emotions in other curriculum subjects were valued. All schools provided some support for students experiencing emotional distress, but the type and quality varied a great deal. Students wanted an increase in school-based help sources that were confidential, available to all and sympathetic, and were concerned that accessing support should not lead to stigma. Finally, staff and students emphasised the need to consider the whole school environment in order to address sources of distress such as bullying and teacher-student relationships, but also to increase activities that enhanced emotional health.
Conclusion:
Staff and students identified several ways in which schools can improve their support of adolescent emotional health, both within and outside the curriculum. However, such changes should be introduced as part of a wider consideration of how the whole school environment can be more supportive of students&apos; emotional health. Clearer guidance at policy level, more rigorous evaluation of current interventions, and greater dissemination of good practice is necessary to ensure adolescents&apos; emotional health needs are addressed effectively within schools.</description>
        <link>http://www.biomedcentral.com/1471-2458/9/403</link>
                <dc:creator>Judi Kidger</dc:creator>
                <dc:creator>Jenny Donovan</dc:creator>
                <dc:creator>Lucy Biddle</dc:creator>
                <dc:creator>Rona Campbell</dc:creator>
                <dc:creator>David Gunnell</dc:creator>
                <dc:source>BMC Public Health 2009, 9:403</dc:source>
        <dc:date>2009-10-31T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2458-9-403</dc:identifier>
        <prism:publicationName>BMC Public Health</prism:publicationName>
        <prism:issn>1471-2458</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>403</prism:startingPage>
        <prism:publicationDate>2009-10-31T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2458/9/51">
        <title>The effect of alcohol advertising, marketing and portrayal on drinking behaviour in young people: systematic review of prospective cohort studies</title>
        <description>Background:
The effect of alcohol portrayals and advertising on the drinking behaviour of young people is a matter of much debate. We evaluated the relationship between exposure to alcohol advertising, marketing and portrayal on subsequent drinking behaviour in young people by systematic review of cohort (longitudinal) studies.
Methods:
studies were identified in October 2006 by searches of electronic databases, with no date restriction, supplemented with hand searches of reference lists of retrieved articles. Cohort studies that evaluated exposure to advertising or marketing or alcohol portrayals and drinking at baseline and assessed drinking behaviour at follow-up in young people were selected and reviewed.
Results:
seven cohort studies that followed up more than 13,000 young people aged 10 to 26 years old were reviewed. The studies evaluated a range of different alcohol advertisement and marketing exposures including print and broadcast media. Two studies measured the hours of TV and music video viewing. All measured drinking behaviour using a variety of outcome measures. Two studies evaluated drinkers and non-drinkers separately. Baseline non-drinkers were significantly more likely to have become a drinker at follow-up with greater exposure to alcohol advertisements. There was little difference in drinking frequency at follow-up in baseline drinkers. In studies that included drinkers and non-drinkers, increased exposure at baseline led to significant increased risk of drinking at follow-up. The strength of the relationship varied between studies but effect sizes were generally modest. All studies controlled for age and gender, however potential confounding factors adjusted for in analyses varied from study to study. Important risk factors such as peer drinking and parental attitudes and behaviour were not adequately accounted for in some studies.
Conclusion:
data from prospective cohort studies suggest there is an association between exposure to alcohol advertising or promotional activity and subsequent alcohol consumption in young people. Inferences about the modest effect sizes found are limited by the potential influence of residual or unmeasured confounding.</description>
        <link>http://www.biomedcentral.com/1471-2458/9/51</link>
                <dc:creator>Lesley Smith</dc:creator>
                <dc:creator>David Foxcroft</dc:creator>
                <dc:source>BMC Public Health 2009, 9:51</dc:source>
        <dc:date>2009-02-06T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2458-9-51</dc:identifier>
        <prism:publicationName>BMC Public Health</prism:publicationName>
        <prism:issn>1471-2458</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>51</prism:startingPage>
        <prism:publicationDate>2009-02-06T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2458/9/395">
        <title>Time series analysis of dengue fever and weather in Guangzhou, China</title>
        <description>Background:
Monitoring and predicting dengue incidence facilitates early public health responses to minimize morbidity and mortality. Weather variables are potential predictors of dengue incidence. This study explored the impact of weather variability on the transmission of dengue fever in the subtropical city of Guangzhou, China.
Methods:
Time series Poisson regression analysis was performed using data on monthly weather variables and monthly notified cases of dengue fever in Guangzhou, China for the period of 2001-2006. Estimates of the Poisson model parameters was implemented using the Generalized Estimating Equation (GEE) approach; the quasi-likelihood based information criterion (QICu) was used to select the most parsimonious model.
Results:
Two best fitting models, with the smallest QICu values, are selected to characterize the relationship between monthly dengue incidence and weather variables. Minimum temperature and wind velocity are significant predictors of dengue incidence. Further inclusion of minimum humidity in the model provides a better fit.
Conclusion:
Minimum temperature and minimum humidity, at a lag of one month, are positively associated with dengue incidence in the subtropical city of Guangzhou, China. Wind velocity is inversely associated with dengue incidence of the same month. These findings should be considered in the prediction of future patterns of dengue transmission.</description>
        <link>http://www.biomedcentral.com/1471-2458/9/395</link>
                <dc:creator>Liang Lu</dc:creator>
                <dc:creator>Hualiang Lin</dc:creator>
                <dc:creator>Linwei Tian</dc:creator>
                <dc:creator>Weizhong Yang</dc:creator>
                <dc:creator>Jimin Sun</dc:creator>
                <dc:creator>Qiyong Liu</dc:creator>
                <dc:source>BMC Public Health 2009, 9:395</dc:source>
        <dc:date>2009-10-27T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2458-9-395</dc:identifier>
        <prism:publicationName>BMC Public Health</prism:publicationName>
        <prism:issn>1471-2458</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>395</prism:startingPage>
        <prism:publicationDate>2009-10-27T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
        <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
    </cc:License>
</rdf:RDF>
